Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007 |
Resumo: | OBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age > 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age > 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function. |
id |
AMB-1_7d45ff5a9d52bf5682d139f42bd4274b |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302013000100007 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertensionPrimary hypertensionChronic kidney diseaseCardiovascular riskGlomerular filtratin ratePrimary careCystatin COBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age > 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age > 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function.Associação Médica Brasileira2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007Revista da Associação Médica Brasileira v.59 n.1 2013reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/S0104-42302013000100007info:eu-repo/semantics/openAccessSalgado,João VictorFrança,Ana KarinaCabral,Nayra AniellyLages,JoyceRibeiro,Valdinar SousaSantos,Alcione MirandaSalgado,Bernardete Jorgeeng2015-07-21T00:00:00Zoai:scielo:S0104-42302013000100007Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2015-07-21T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
title |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
spellingShingle |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension Salgado,João Victor Primary hypertension Chronic kidney disease Cardiovascular risk Glomerular filtratin rate Primary care Cystatin C |
title_short |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
title_full |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
title_fullStr |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
title_full_unstemmed |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
title_sort |
Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension |
author |
Salgado,João Victor |
author_facet |
Salgado,João Victor França,Ana Karina Cabral,Nayra Anielly Lages,Joyce Ribeiro,Valdinar Sousa Santos,Alcione Miranda Salgado,Bernardete Jorge |
author_role |
author |
author2 |
França,Ana Karina Cabral,Nayra Anielly Lages,Joyce Ribeiro,Valdinar Sousa Santos,Alcione Miranda Salgado,Bernardete Jorge |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Salgado,João Victor França,Ana Karina Cabral,Nayra Anielly Lages,Joyce Ribeiro,Valdinar Sousa Santos,Alcione Miranda Salgado,Bernardete Jorge |
dc.subject.por.fl_str_mv |
Primary hypertension Chronic kidney disease Cardiovascular risk Glomerular filtratin rate Primary care Cystatin C |
topic |
Primary hypertension Chronic kidney disease Cardiovascular risk Glomerular filtratin rate Primary care Cystatin C |
description |
OBJECTIVE: To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS: A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included measurements of serum creatinine (Scr) and Scys levels, 24-hour microalbuminuria (MA), as well as glomerular filtration rate (GFR) through Larsson and Modification of Diet in Renal Disease (MDRD) study equations. Bland- Altman plot analysis was used to calculate the agreement between equations. RESULTS: High levels of Scys were found in 22% of the patients, even with normal values of GFR estimated by MDRD study equation. Systolic blood pressure and MA correlated better with Scys than Scr, but there was no correlation between Scys and diastolic blood pressure. Gender, age > 60 years, MA, and uric acid were significantly associated with high Scys levels. After multivariate analysis, only age > 60 yrs (RR = 6.4; p < 0.001) and male gender (RR = 3.0; p = 0.006) remained associated with high Scys levels. CONCLUSION: Cystatin C can be used as a screening marker both for detecting mild declines of renal function and for preventing the risk of cardiovascular events in hypertensive subjects with presumably normal renal function. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000100007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0104-42302013000100007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.59 n.1 2013 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212830684381184 |